These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 19765463

  • 21. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
    Kim JM, Lee SK, Kim SJ, Joh JW, Kwon CH, Choe YH, Shin M, Kim EY, Moon JI, Jung GO, Choi GS.
    Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
    [Abstract] [Full Text] [Related]

  • 22. Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms.
    Thomas de Montpréville V, Le Pavec J, Le Roy Ladurie F, Crutu A, Mussot S, Fabre D, Mercier O, Dorfmuller P, Ghigna MR, Fadel É.
    Respiration; 2015 Apr; 90(6):451-459. PubMed ID: 26506523
    [Abstract] [Full Text] [Related]

  • 23. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H, Oschlies I, Fink S, Pott C, Neumayer HH, Lehmkuhl H, Hauser IA, Dreyling M, Kneba M, Gärtner B, Anagnostopoulos I, Riess H, Klapper W, Trappe RU.
    Transplantation; 2012 Mar 15; 93(5):543-50. PubMed ID: 22234349
    [Abstract] [Full Text] [Related]

  • 24. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A.
    Liver Transpl; 2007 Jun 15; 13(6):904-12. PubMed ID: 17539010
    [Abstract] [Full Text] [Related]

  • 25. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
    Mirza EI, Mutluay R, Suyani E, Okyay GU, Akyurek N, Aki SZ, Derici U, Arinsoy T.
    Exp Clin Transplant; 2011 Dec 15; 9(6):425-8. PubMed ID: 22142053
    [Abstract] [Full Text] [Related]

  • 26. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
    Ziarkiewicz-Wróblewska B, Górnicka B, Suleiman W, Ołdakowska-Jedynak U, Wróblewski T, Bogdańska M, Ziółkowski J, Nowacka-Cieciura E, Foroncewicz B, Pileri SA, Durlik M, Paczek L, Krawczyk M, Wasiutyński A.
    Transplant Proc; 2006 Dec 15; 38(1):168-72. PubMed ID: 16504694
    [Abstract] [Full Text] [Related]

  • 27. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case.
    Shitrit D, Shitrit AB, Dickman R, Sahar G, Saute M, Kramer MR.
    Dis Colon Rectum; 2005 Nov 15; 48(11):2144-7. PubMed ID: 16086224
    [Abstract] [Full Text] [Related]

  • 28. Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
    Krieger NR, Martinez OM, Krams SM, Cox K, So S, Esquivel CO.
    Liver Transpl; 2000 Jan 15; 6(1):62-6. PubMed ID: 10648579
    [Abstract] [Full Text] [Related]

  • 29. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG.
    J Heart Lung Transplant; 1995 Jan 15; 14(2):214-21. PubMed ID: 7779838
    [Abstract] [Full Text] [Related]

  • 30. More benign lymphoproliferative disease after liver transplant in infants.
    Khedmat H, Ghamar-Chehreh ME, Amini M, Taheri S.
    Prog Transplant; 2013 Jun 15; 23(2):158-64. PubMed ID: 23782664
    [Abstract] [Full Text] [Related]

  • 31. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
    Akar Özkan E, Özdemir BH, Akdur A, Deniz EE, Haberal M.
    Exp Clin Transplant; 2014 Mar 15; 12 Suppl 1():136-8. PubMed ID: 24635811
    [Abstract] [Full Text] [Related]

  • 32. Liver transplantation at the University of Chicago.
    Millis JM, Alonso EM, Piper JB, Bruce DS, Newell KA, Woodle ES, Baker AL, Whitington PF, Thistlethwaite JR.
    Clin Transpl; 1995 Mar 15; ():187-97. PubMed ID: 8794265
    [Abstract] [Full Text] [Related]

  • 33. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
    Milpied N, Vasseur B, Parquet N, Garnier JL, Antoine C, Quartier P, Carret AS, Bouscary D, Faye A, Bourbigot B, Reguerre Y, Stoppa AM, Bourquard P, Hurault de Ligny B, Dubief F, Mathieu-Boue A, Leblond V.
    Ann Oncol; 2000 Mar 15; 11 Suppl 1():113-6. PubMed ID: 10707791
    [Abstract] [Full Text] [Related]

  • 34. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

  • 35. Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study.
    Lo RC, Chan SC, Chan KL, Chiang AK, Lo CM, Ng IO.
    J Clin Pathol; 2013 May 15; 66(5):392-8. PubMed ID: 23423516
    [Abstract] [Full Text] [Related]

  • 36. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
    Caillard S, Lachat V, Moulin B.
    Transpl Int; 2000 May 15; 13 Suppl 1():S388-93. PubMed ID: 11112039
    [Abstract] [Full Text] [Related]

  • 37. Post-liver transplantation lymphoproliferative disorders with and without infusions of donor bone marrow cells.
    Restrepo A, Albrecht F, Raez LE, Fernandez HF, Nassiri M, Byrne G, Cassileth PA.
    Crit Rev Oncog; 1999 May 15; 10(3):239-45. PubMed ID: 10468183
    [Abstract] [Full Text] [Related]

  • 38. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
    Montanari F, O'Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, Crook MT, Tsao L, Sevilla DW, Bhagat G, Alobeid B.
    Hum Pathol; 2010 Aug 15; 41(8):1150-8. PubMed ID: 20381113
    [Abstract] [Full Text] [Related]

  • 39. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M, Marciano S, dos Santos Schraiber L, Zapata R, Quiros R, Zanotelli ML, Rivas MM, Kusminsky G, Humeres R, Alves de Mattos A, Gadano A, Silva MO.
    Clin Transplant; 2013 Aug 15; 27(4):E469-77. PubMed ID: 23758407
    [Abstract] [Full Text] [Related]

  • 40. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.
    Am J Surg Pathol; 2006 Mar 15; 30(3):328-36. PubMed ID: 16538052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.